West Pharmaceutical Servs Q4 Adjusted EPS $1.83 Beats $1.78 Estimate, Sales $732.00M Miss $739.47M Estimate
Portfolio Pulse from Benzinga Newsdesk
West Pharmaceutical Servs (WST) reported Q4 adjusted EPS of $1.83, surpassing the $1.78 estimate, and sales of $732.00M, slightly below the $739.47M estimate. This represents a 3.39% increase in EPS and a 3.29% increase in sales from the same period last year.
February 15, 2024 | 11:02 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
West Pharmaceutical Servs reported a mixed Q4 with an EPS beat and a slight sales miss, showing growth from the previous year.
The mixed results with an EPS beat and a slight sales miss could lead to neutral market reaction in the short term. The growth in both EPS and sales compared to the previous year indicates underlying strength, but the sales miss might temper immediate positive sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100